Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 2

1(25.0%)

4Total

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07574632Not ApplicableNot Yet Recruiting

A Study to Evaluate a New Semi-rigid Brace, the RESILIENT Brace by Thinks Works, as a Way to Limit Curve Worsening in Kids With Idiopathic Scoliosis.

Role: collaborator

NCT06362239Enrolling By Invitation

Prospective Home-Based Palliative Care and Hospice Study

Role: collaborator

NCT01193075Recruiting

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Role: collaborator

NCT05764681Recruiting

Chronic Postsurgical Pain

Role: collaborator

NCT02930824Not ApplicableCompleted

Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing

Role: collaborator

NCT02167022Not ApplicableCompleted

Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy

Role: collaborator

NCT02167217Phase 2Completed

Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy

Role: collaborator

NCT02979145Unknown

Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)

Role: collaborator

All 8 trials loaded